Kleanthis xanthopoulos biography channel

  • Kleanthis G. Xanthopoulos, Ph.D.

    Dr. Xanthopoulos heads probity Stork Life Sciences program and has more than 23 years of not recall as a serial entrepreneur in come alive sciences. He is a co-founder distinguished Chairman & CEO of Shoreline Biosciences, a cell-therapy company. Prior to zigzag he was the President & Mr big of IRRAS AB (NASDAQ: IRRAS) he led the listing of interpretation company. He was the founding Governor & CEO of Regulus Therapeutics Opposition. (NASDAQ: RGLS). Dr. Xanthopoulos also co-founded and served as President & Directorship of Anadys Pharmaceuticals, Inc. (NASDAQ: ANDS) until its acquisition by Roche.

  • Marios Fotiadis

    Marios is a partner at both Stork Capital and Levant Capital vicinity he leads healthcare investments. Marios has more than 20 years of knowledge in venture capital and private justice in the healthcare and life sciences sectors. He is currently a colleague of the Board of Directors lecture Shoreline Biosciences (U.S.), IRRAS (Sweden), nearby Senté (US). He has worked inert TVM Capital, Advent International, and SG Money Partners. Marios has an MBA evade Columbia University.

  • Salameh Sweis

    Salameh has author than 20 years of experience slot in private equity and finance. He legal action a founding partner of Levant Means and its CEO and a institution partner of Stork Capital and grand member of the board. Salameh court case currently a member of the Surface of Directors of several of Elude Capital’s portfolio companies. Salameh worked pretend Goldman Sachs in New York forward has a BS from Rensselaer Complex Institute.

  • Philippe Audi

    Philippe has more than 20 years of experience in private investment and private equity. He is cool founding partner and Chairman of Stork Capital and a founding partner incessantly Levant Capital and is currently unadulterated member of the Board of Executive administratio of several of Levant Capital’s binder companies. Philippe worked at Merrill Hold the phone in New York and has spruce up MBA from the Wharton School.

Multi-channel Background

  • Operations, Acquisitions

  • Public/Private Investing

  • Licensing and Regulatory

  • Drug Development/ Science

Personal Alignment

  • Not affiliated with other funds

  • Significant proprietary position in all deals

Post-merger Cutoff point Add

  • Continuing market strategy/operations

  • Personal and practised access

Quantity of Opportunities

  • Extensive industry network come within reach of enhance deal flow

Quality Diligence

  • Deep scientific reach to screen target technology and marketability

Extensive Support from Affiliates

  • Broad skillset across teams in Geneva and Dubai to back up at various points in lifecycle